Hypnoanalgesia for Dermatological Surgery in Children

Sponsor
Complejo Hospitalario de Toledo (Other)
Overall Status
Completed
CT.gov ID
NCT04707014
Collaborator
(none)
28
1
2
5.9
4.7

Study Details

Study Description

Brief Summary

This randomized clinical trial will evaluate the effect of hypnosedation on the need of sedation and analgesia in a pediatric population undergoing dermatological surgery, both during the procedure, and 24 hours after surgery. In addition, a secondary objetive is to evaluate the effect by specific age groups.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Hypnosis
  • Behavioral: Attention-distracting techniques
N/A

Detailed Description

In this clinical trial, pediatric patients scheduled for removal of benign skin lesions in a single center willbe randomised to receive hypnosis (intervention group) or attention-distracting techniques (control group). Endpoints will be the sedative dose (propofol) during surgery, and the need for analgesia (paracetamol and others) immediately after surgery (recovery) and after 24 hours. Randomization will be systematic in blocks depending on the day the surgery is programmed. Hypnosis will be delivered by an experienced anesthesist trained in the technique. Patients and families will be informed of the special treatment during surgery, but will be unaware of whether the patients are experiencing distraction or hypnosis techniques. Distraction is already a useful technique, and it is expected that patients will be satisfied with the procedure; however, the hypothesis to be tested is that hypnosis reduces the need for sedation and analgesia compared to distraction techniques, as well as improves satisfaction.

Study Design

Study Type:
Interventional
Actual Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients are randomly distributed to one of the following groups: Intervention group: Technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening. Control group: High-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure.Patients are randomly distributed to one of the following groups:Intervention group: Technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening. Control group: High-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure.
Masking:
Single (Outcomes Assessor)
Masking Description:
Different investigators are assigned to each phase of the study, with one designated as responsible for recruitment (MQD), another for intervention and control (JMPP), and another for subsequent evaluation in the post-anaesthesia recovery unit (URPA) and at 24 hours (responsible nursing staff).
Primary Purpose:
Other
Official Title:
Effectiveness of Hypnoanalgesia for Dermatological Surgery in Children: Randomised Clinical Trial
Actual Study Start Date :
Nov 1, 2017
Actual Primary Completion Date :
Apr 15, 2018
Actual Study Completion Date :
Apr 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Attention-Distraction techniques

A high-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure.

Behavioral: Attention-distracting techniques
i-pad with movies, games and music

Experimental: HIPNOSIS GROUP

A technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to the child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening.

Behavioral: Hypnosis
Rapid conversational hypnosis
Other Names:
  • Hypnoanalgesia
  • Hypnosedation
  • Outcome Measures

    Primary Outcome Measures

    1. Total dose of propofol in mg/kg [During surgery (Intra-operative)]

      Measured in mg/kg weight

    2. Total dose of propofol in mg [During surgery (Intra-operative)]

      Measured in total mg

    3. Additional need for opioids during surgery [During surgery (Intra-operative)]

      Yes/no

    Secondary Outcome Measures

    1. Pain intensity in older children post-operative [Immediately post-operative while on recovery unit]

      0-10 visual analogue scale (VAS) administered by a blinded nurse, with higher values indicating higher levels of pain

    2. Pain intensity in younger children post-operative [Immediately post-operative while on recovery unit]

      0-10 Faces Pain Scale - Revised (FPS-r) administered by a blinded nurse, with higher values indicating higher levels of pain

    3. Pain intensity in older children after 24 hours [24 hours after discharge]

      0-10 visual analogue scale (VAS) administered over the phone by a blinded nurse, with higher values indicating higher levels of pain

    4. Pain intensity in younger children after 24 hours [24 hours after discharge]

      0-10 Faces Pain Scale - Revised (FPS-r) administered over the phone by a blinded nurse, with higher values indicating higher levels of pain

    5. Analgesic need [24 hours after discharge]

      Recorded by a blinded nurse at reanimation unit as yes/no

    6. Analgesic needs [24 hours after discharge]

      Recorded by a blinded nurse by telephone call as yes/no

    Other Outcome Measures

    1. Degree of satisfaction with the procedure [24 hours after discharge]

      Validated survey with score 1-10 administered at the time of discharge to children and their guardians.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 16 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. A class I or II of anaesthetic risk according to the American Society of Anesthesiologists,

    2. to be in a percentile between P3 and P97 in weight and height,

    3. without known drug allergies, and

    4. having fasted 6 hours for solids and 2 hours for water.

    Exclusion Criteria:
    1. Children with diagnosed mental retardation or attention deficit,

    2. behavioural disorders,

    3. previous treatment with hypnosis,

    4. history of neurological pathology or psychomotor retardation,

    5. previous pain-related pathology,

    6. obstructive sleep apnoea syndrome (OSAS)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Complejo Hospitalario Toledo Toledo Spain 45002

    Sponsors and Collaborators

    • Complejo Hospitalario de Toledo

    Investigators

    • Principal Investigator: Juana Maria PELAEZ PEREZ, PH, Complejo Hospitalario Toledo

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    JUANA MARIA PELAEZ PEREZ, Anesthesiologist, Complejo Hospitalario de Toledo
    ClinicalTrials.gov Identifier:
    NCT04707014
    Other Study ID Numbers:
    • CHT00028
    First Posted:
    Jan 13, 2021
    Last Update Posted:
    Jan 13, 2021
    Last Verified:
    Jan 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by JUANA MARIA PELAEZ PEREZ, Anesthesiologist, Complejo Hospitalario de Toledo

    Study Results

    No Results Posted as of Jan 13, 2021